NCT00240019已完成不适用
Maximizing the Benefit of RAS Blockade in Diabetic Nephropathy
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 30
- 试验地点
- 4
- 主要终点
- The amount of protein in the urine after 8 weeks of treatment.
研究概览
简要总结
The angiotensin converting enzyme inhibitor drugs are now standard therapy for patients with diabetic nephropathy. The hypothesis of this study is that adding a diuretic agent (furosemide) will decrease the urine protein, which is a sign of disease, more than an angiotensin converting enzyme inhibitor alone.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •proteinuria greater than 1 gram/day serum creatinine < 2.6 for men, < 2.0 for women
排除标准
- •blood pressure which cannot be controlled without a diuretic renal diseases other than diabetic nephropathy other disease which would alter renal function during 6 months
结局指标
主要结局
The amount of protein in the urine after 8 weeks of treatment.
次要结局
- The estimated glomerular filtration rate after 8 weeks of treatment.
研究者
研究点 (4)
Loading locations...
相似试验
已完成
4 期
Telmisartan and Losartan in Hypertensive IGTImpaired Glucose ToleranceHypertensionNCT00407862Medical University of Graz24
终止
3 期
VA NEPHRON-D: Diabetes iN Nephropathy StudyNephropathyType 2 DiabetesKidney DiseaseNCT00555217US Department of Veterans Affairs1,448
已完成
不适用
Renin Angiotensin SyStem blockade: diabetes nephropathyISRCTN65752530Canadian Institutes of Health Research (CIHR) (Canada)223
终止
2 期
Treatment of Angiotensin Converting Enzyme Inhibitor-induced AngioedemaAngioedema Caused by Angiotensin-Converting-Enzyme InhibitorNCT04679311Washington University School of Medicine2
已完成
不适用
RAAS-blockade in type II diabetes: added effects of a low sodium diet and diuretics.diabetesNL-OMON35646niversitair Medisch Centrum Groningen55